[HTML][HTML] Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes

A Prat, O Karginova, JS Parker, C Fan, X He… - Breast cancer research …, 2013 - Springer
A Prat, O Karginova, JS Parker, C Fan, X He, L Bixby, JC Harrell, E Roman, B Adamo…
Breast cancer research and treatment, 2013Springer
Five molecular subtypes (luminal A, luminal B, HER2-enriched, basal-like, and claudin-low)
with clinical implications exist in breast cancer. Here, we evaluated the molecular and
phenotypic relationships of (1) a large in vitro panel of human breast cancer cell lines
(BCCLs), human mammary fibroblasts (HMFs), and human mammary epithelial cells
(HMECs);(2) in vivo breast tumors;(3) normal breast cell subpopulations;(4) human
embryonic stem cells (hESCs); and (5) bone marrow-derived mesenchymal stem cells …
Abstract
Five molecular subtypes (luminal A, luminal B, HER2-enriched, basal-like, and claudin-low) with clinical implications exist in breast cancer. Here, we evaluated the molecular and phenotypic relationships of (1) a large in vitro panel of human breast cancer cell lines (BCCLs), human mammary fibroblasts (HMFs), and human mammary epithelial cells (HMECs); (2) in vivo breast tumors; (3) normal breast cell subpopulations; (4) human embryonic stem cells (hESCs); and (5) bone marrow-derived mesenchymal stem cells (hMSC). First, by integrating genomic data of 337 breast tumor samples with 93 cell lines we were able to identify all the intrinsic tumor subtypes in the cell lines, except for luminal A. Secondly, we observed that the cell lines recapitulate the differentiation hierarchy detected in the normal mammary gland, with claudin-low BCCLs and HMFs cells showing a stromal phenotype, HMECs showing a mammary stem cell/bipotent progenitor phenotype, basal-like cells showing a luminal progenitor phenotype, and luminal B cell lines showing a mature luminal phenotype. Thirdly, we identified basal-like and highly migratory claudin-low subpopulations of cells within a subset of triple-negative BCCLs (SUM149PT, HCC1143, and HCC38). Interestingly, both subpopulations within SUM149PT were enriched for tumor-initiating cells, but the basal-like subpopulation grew tumors faster than the claudin-low subpopulation. Finally, claudin-low BCCLs resembled the phenotype of hMSCs, whereas hESCs cells showed an epithelial phenotype without basal or luminal differentiation. The results presented here help to improve our understanding of the wide range of breast cancer cell line models through the appropriate pairing of cell lines with relevant in vivo tumor and normal cell counterparts.
Springer